The Full Story

" Imagine a world where you can know your health status with a simple breath while brushing your teeth.  A world where you can detect diseases early before they have a chance to cause serious harm. A world where you can take control of your health and live a longer, healthier life.

​

This is the world that we are creating with our new diagnostic medical device. The device is

a portable, personal, and non-habit-changing device, for home use. It can analyze in real-time your body for a wide range of diseases, including cancer, heart disease, diabetes, periodontitis, and others. And it can do all of this in real-time.

​

We believe that this device has the potential to revolutionize healthcare. It can help people to live longer, healthier lives. It can help to significantly reduce the cost of healthcare. And it can help make healthcare more accessible to everyone.

 

We are excited to share this device with the world in 2025. We believe that it has the power to change lives. "

                                                                                               Dr. Max Arocha

​

​

Dr. Max Arocha professional journey started as a young pre-med student at Florida Atlantic University, Dr. Arocha, then known as “Max,” was sitting at the dinner table with his parents.  As his mother, Maritza, served dinner, his father, Mike, delivered devastating news.  He could either lose all of his teeth or try a $5,000 surgery that wasn’t a guarantee.  Mike, only 50 years old at the time, had periodontal disease.

 

Max found it unfathomable that there wasn’t an antibiotic to treat his father’s periodontal infection.  Max changed his major from biology to a dual major in biochemistry and microbiology, inspired by the idea of helping his father and others like him.

 

At Temple University’s School of Dentistry, Max studied under Dr. Rams, a professor, and Director of the Oral Microbiology Testing Service Laboratory at Temple University’s School of Dentistry.  Dr. Rams is considered the “guru” of non-surgical periodontal therapy for the treatment of periodontal disease.

 

As a dentist, Dr. Arocha has been able to save his father’s teeth.  Others haven’t been as fortunate, often having as many as 20 infected teeth extracted.

​

Dr. Arocha determination led him to become an innovator in numerous novel anesthetics, non-surgical periodontal medical devices, and nanotechnology antibiotics including PerioER™ devices which have FDA clearance. During his biotechnology reach and development years, Dr Arocha created PharmaPhD in 2013 which is about more than just creating local antibiotic systems to treat periodontal disease.  PharmaPhD was born, in essence, to provide patients with hope about saving their teeth, taking away the psychological trauma that comes with the news that one’s teeth cannot be saved.

​

 

Seeking a new challenge in his life and realizing that exhaled breath is a vast untapped resource of biological information, Dr Arocha started to focus on the breath biomarkers a few years after his mother was diagnosed with Parkinson's disease. Her life quality deteriorated dramatically as a result of a late diagnosis.

 

Looking in the mirror, over a decade after creating an antibiotic therapy system for his father, Dr. Arocha sees himself with graying hair.  Past his hair, he now sees the hope, determination, and passion to introduce toothbrushAi as a product designed to be easy to use for individuals and also designed to protect patient data and be accessible to everyone.

 

ToothbrushAi is a groundbreaking device that identifies, analyzes, and monitors airborne biomarkers from the breath and personal skin odor cloud while users are brushing their teeth. ToothbrushAi detects in real-time a variety of diseases, including cancer, diabetes, respiratory infections, liver disease, Parkinson's disease, periodontitis, and others.

​

The ToothbrushAi system in concept comes from the knowledge that our bodies emit health signals 24/7 through our breath and skin. It's our body's secret language and up until now, nobody was listening. Dr Arocha is changing that. He is building the world's first at-home disease diagnostics airborne biomarker perception platform that can decode these signals and unlock a new era of healthcare.

​

ToothbrushAi early motivation comes from information that dogs have smell receptors about 10,000 times more accurate than humans, making them highly sensitive to airborne biomarkers and odors we can't perceive. A new study has shown that dogs can use their highly evolved sense of smell to pick out blood samples from people with cancer with almost 97 percent accuracy. The results have led to a new ToothbrushAi cancer and other diagnostics screening system that is inexpensive and accurate without being invasive. ToothbrushAi works like a dog odor perception with superhuman abilities.

​

Nature has been perfecting our odor perception for 7 million years: a tough act to follow. So, instead of trying to reinvent a masterpiece, Dr. Arocha chose to replicate it in a personal and non-habit-changing device, for home use, a smart toothbrush. Dog odor perception — the ability to smell — consists of four key functions, and the technology behind ToothbrushAi mimics all four, faithfully and precisely.

​

In South Florida, Dr. Arocha has been able to help hundreds of patients a year.  His vision doesn’t stop within the borders of Florida. Dr. Arocha now wants to reach out to help millions of patients worldwide, like his mother, who was a victim of a late medical diagnosis.

​